Acceptance and Commitment Therapy for Coronary Artery Bypass Graft Surgery Patients

This study is looking at how Acceptance and Commitment Therapy (ACT) can help patients undergoing coronary artery bypass graft (CABG) surgery. CABG is a surgery for heart disease that helps improve chest pain. ACT is a type of therapy that helps people become more flexible in their thinking and accept difficult thoughts and feelings. Researchers want to see if ACT can help patients after CABG surgery. You might be able to join if you are between 18 and 80 years old, are having CABG surgery at the University of Iowa Hospitals and Clinics, can speak English, and have a phone or device for video/audio calls. The study will measure how acceptable the therapy is, how satisfied participants are, and how well they stick with the therapy, all at 8 weeks after starting.

Study design
This study is an interventional study with a planned enrollment of 30 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for at least 8 weeks to assess the therapy's acceptability, satisfaction, and adherence.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06207318

Acceptance and Commitment Therapy for Patients Undergoing Coronary Artery Bypass Graft Surgery

Recruiting
NAAges 18–80InterventionalSupportive care
University of Iowa
~30 participants
Updated 2025-08-08 on ClinicalTrials.gov
What's tested:Acceptance and commitment therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Theoretical Framework of Acceptability (TFA) questionnaire
Measured over 8 weeks
+6 more outcomes measured
Coronary Artery Disease
Vascularization
1 sites across 1 states
Iowa1
  • Sara J Diesel, MA · PRINCIPAL_INVESTIGATOR · University of Iowa

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

admission to the Heart and Vascular Center at University of Iowa Hospitals and Clinics (UIHC) for urgent or elective CABG
access to a personal phone or device with video or audio capabilities
ability to provide informed consent
English fluency.

Exclusion

life-threatening comorbid (noncardiac) medical condition(s)
active suicidal ideation or intent
psychotropic medication use lasting less than four weeks
inability to provide informed consent and comply with study procedures
those undergoing repeat revascularization
  • Theoretical Framework of Acceptability (TFA) questionnaire8 weeks

    The TFA is comprised of seven constructs: affective attitude, burden, ethicality, perceived effectiveness, intervention coherence, self-efficacy, and opportunity costs, and also includes an overall acceptability rating. The TFA can be used to generate a single acceptability score and/or to assess the unique domains of acceptability included in the model. Scale scores range from minimum values of 7, and maximum values of 35, with higher scores indicating higher acceptability.

  • Participant Satisfaction measure8 weeks

    Participants will answer five questions on a 5-point Likert-type scale (1 = not at all, 5 = extremely). Scale scores range from minimum values of 5, and maximum values of 25, with higher scores indicating higher satisfaction.

  • Participant Adherence measure8 weeks

    The extent to which participants adhere to the intervention will be assessed via a self-rated measure in which completion of between-session mindfulness and reflection exercises will be reported. Participants will answer four yes/no items. Scale scores range from minimum values of 0, and maximum values of 4, with higher scores indicating higher adherence.

  • Participant EnrollmentBaseline

    The number and percentage of patients undergoing CABG who are eligible for the study will be tracked as well as the number of participants enrolled in the study. These values will be used to determine the enrollment rate. Additionally, the investigators will track basic patient characteristics such that representativeness of the enrolled sample may be compared to all eligible patients who were approached.

  • Intervention Delivery8 weeks

    Treatment fidelity will be assessed via coder-rated evaluation of interventionist adherence to the manualized treatment protocol. The coder will be a licensed therapist with specific expertise in ACT therapeutic principles and psychotherapy. A randomly selected 20% of sessions will be assessed for treatment fidelity and intervention adherence.

  • Completion of Study Procedures8 weeks

    Completion of all psychological, acceptance, satisfaction, and adherence measures will also be assessed. This will include completion of the entire measure as well as per-item completion which will be recorded for each participant in order to quantify missing data. Attendance will be recorded by the interventionist at each session.

  • Retention8 weeks

    The investigators will assess retention rate by tracking the proportion of enrolled participants who complete all intervention sessions and study procedures.